Lu Ni

Lu Ni

Auto-generated profile, based on publicly available information

Lu Ni

The Institute of Scientific and Industrial Research, Osaka University, Ibaraki 567-0047, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TYTakeshi Yamada
Takeshi Yamada
SMShouta Miki
Shouta Miki
LNLu Ni
Lu Ni
KNKazuhiko Nakatani
Kazuhiko Nakatani
A new DNA binding small molecule, NCD-CC is reported. NCD-CC has a NCD domain, which recognizes the G–G mismatch in a CGG/CGG triad, and a cysteinylcystein (CC) moiety. Dimerization of NCD-CC through intermolecular disulfide bond formation was accelerated in the presence of CGG repeat DNA.

17 April 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LNLu Ni
Lu Ni
TYTakeshi Yamada
Takeshi Yamada
KNKazuhiko Nakatani
Kazuhiko Nakatani
Herein, we show two new DNA binding small molecules, NCD-RO and NCD-RC, and their ability to bind and selectively assemble ruthenium complexes on G–G mismatch DNA. This study used a naphthyridine carbamate dimer (NCD) as an efficient scaffold to assemble metal complexes in a controlled manner on dsDNA.

24 February 2022 in Chemical Communications
Verified
Journal Article
Open access
PDF file
LNLu Ni
Lu Ni
TYTakeshi Yamada
Takeshi Yamada
AMAsako Murata
Asako Murata
KNKazuhiko Nakatani
Kazuhiko Nakatani
Circular RNAs (circRNA) are covalently-closed single stranded RNAs with potent roles in cells. Here, we demonstrate the feasibility of mediating circRNA production in a model environment via a small molecule: naphthyridine carbamate dimer (NCD).

14 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LNLu Ni
Lu Ni
TMTakuya Murakami
Takuya Murakami
SSSatoshi Suzuki
Satoshi Suzuki
MHMari Hamao
Mari Hamao
MNMichiko Nakamura
Michiko Nakamura
KTKazutoshi Takahashi
Kazutoshi Takahashi
Advances in transcriptome profiling have revealed transcriptomic differences across different cellular states. However, functional interpretation requires precise perturbation tools and experimental frameworks. This study benchmarked two widely used modalities: CRISPR interference (CRISPRi) and Cas13d/CasRx. A standardized workflow was established to generate human pluripotent stem cells (PSCs) with inducible ZIM3-dCas9 or CasRx expression. The cell lines were subjected to flow cytometry, copy number, and immunocytochemical analyses. The knockdown performance was validated via robust OCT4 suppression and the expected downstream effects on pluripotency genes. Time-course measurements indicated that CRISPRi produced faster and stronger repression but slower recovery after inducer withdrawal. In contrast, CasRx yielded slower and typically weaker knockdown with rapid reversibility. Furthermore, a key limitation of CRISPRi was demonstrated using the ATF5 - NUP62 locus, wherein CRISPRi could co-repress genes with overlapping promoter regions. In contrast, CasRx avoids these limitations and supports isoform-resolved targeting of circular and alternatively spliced transcripts, albeit with variable efficiency. These results provide practical guidance for selecting complementary knockdown tools to improve the interpretability of transcriptomic function studies. MOTIVATION: Advances in transcriptome profiling have enabled the detection of subtle cell type-specific differences. However, mechanistic interpretation still depends on perturbation tools that can modulate transcripts with high precision and efficiency. Recent CRISPR-based modalities, CRISPRi and Cas13/CasRx, function as robust and orthogonal methods to achieve the knockdown of specific gene targets. However, a standardized approach for cell line preparation and comparative studies on their relative performances and limitations remains unclear. Consequently, this study presents a standardized workflow for generating cell lines that support high-efficiency knockdown using CRISPRi and CasRx. Moreover, it compares the trade-offs in potency, reversibility, and isoform resolution, along with a practical overview of method-specific pitfalls to guide tool selection and data interpretation in future studies. HIGHLIGHTS: Doxycycline-inducible AAVS1 knock-in human PSC platforms for CRISPRi (ZIM3-dCas9) and CasRx (RfxCas13d) were generated to enable standardized RNA perturbation experiments. The prepared cell lines demonstrated strong OCT4 knockdown, with expected downstream effects on the expression of another pluripotency gene, NANOG . A comparison of knockdown characteristics and their reversibility revealed rapid and sustained repression with CRISPRi, whereas slow but rapid recovery was observed with CasRx. A CRISPRi-specific off-target effect arising from TSS proximity/overlap ( ATF5 - NUP62 ) was identified, whereas CasRx achieved ATF5 knockdown without collateral repression of the neighboring NUP62 gene. CasRx enables isoform-resolved knockdown of structural isoforms (circHIPK3 vs. linear HIPK3 mRNA) and splice isoforms (RAB6A-iso1 vs. RAB6A-iso2).